ALEXANDRIA, Va., June 16 -- United States Patent no. 12,303,555, issued on May 20, was assigned to Nanyang Technological University (Singapore) and NATIONAL SKIN CENTER (S) PTE LTD (Singapore).

"Targeting of melanocytes for delivering therapeutic or diagnostic agents using protein nanocages" was invented by Sierin Lim (Singapore), Sathyamoorthy Bhaskar (Singapore), Steven Thng (Singapore), Ambili Kuniyil (Singapore) and Sarker Mridul (Singapore).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to protein nanocages comprising a melanocyte-targeting moiety and pharmaceutical compositions comprising the protein cages as well as methods for treating or diagnosing hyperpigmentation diso...